首页|神经康复治疗在脑卒中偏瘫患者中的临床效果研究

神经康复治疗在脑卒中偏瘫患者中的临床效果研究

扫码查看
目的 分析神经康复治疗在脑卒中偏瘫患者中的临床疗效.方法 100例脑卒中偏瘫患者,采用简单化随机法分为对照组和研究组,每组 50 例.对照组患者采用传统康复治疗,研究组患者实施神经康复治疗.观察并比较两组患者的临床效果、Fugl-Meyer 评估量表(FMA)上肢运动功能评分、美国国立卫生院卒中量表(NIHSS)评分、日常生活活动能力量表(ADL)评分、抑郁自评量表(SDS)评分和焦虑自评量表(SAS)评分.结果 研究组患者的临床总有效率为 98.0%,高于对照组的 86.0%(P<0.05).与治疗前比较,两组患者治疗后的NIHSS评分、FMA上肢运动功能评分均有所改善(P<0.05);研究组患者治疗后的NIHSS评分(13.27±1.08)分低于对照组的(19.68±1.65)分,FMA上肢运动功能评分(47.58±3.86)分高于对照组的(39.12±3.30)分(P<0.05).与治疗前比较,两组患者治疗后的ADL评分均明显升高(P<0.05);研究组患者治疗后的ADL评分(76.39±15.25)分高于对照组的(63.67±12.31)分(P<0.05).与治疗前比较,两组患者治疗后的SDS、SAS评分均有所降低(P<0.05);研究组患者治疗后的SDS、SAS评分分别为(20.35±2.18)、(19.58±2.06)分,显著低于对照组的(26.52±2.75)、(25.25±2.61)分(P<0.05).结论 神经康复治疗在脑卒中偏瘫患者中的临床疗效显著,明显优于常规康复治疗,且能够有效改善患者的神经功能和上肢运动功能,提高患者的日常生活活动能力,降低患者焦虑、抑郁等不良情绪,缩短患者的康复周期,值得临床推广使用.
Study on the clinical effect of neurorehabilitation therapy in patients with post-stroke hemiplegia
Objective To analyze the clinical effect of neurorehabilitation therapy in patients with post-stroke hemiplegia.Methods 100 patients with post-stroke hemiplegia were divided into a control group and a study group by simplified random method,with 50 cases in each group.The control group received conventional rehabilitation therapy,and the study group received neurorehabilitation therapy.Observation and comparison were made on clinical effects,Fugl-Meyer Assessment(FMA)score of the upper extremity,National Institutes of Health Stroke Scale(NIHSS)score,Activities of Daily Living Scale(ADL)score,Self-rating Depression Scale(SDS)score and Self-rating Anxiety Scale(SAS)score between the two groups.Results The total clinical effective rate of the study group was 98.0%,which was higher than 86.0%of the control group(P<0.05).Compared with before treatment,NIHSS score and FMA score of the upper extremity in both groups were improved after treatment(P<0.05).The study group had lower NIHSS score of(13.27±1.08)points than(19.68±1.65)points in the control group,and higher FMA score of the upper extremity of(47.58±3.86)points than(39.12±3.30)points in the control group(P<0.05).Compared with before treatment,ADL scores in both groups increased significantly after treatment(P<0.05).After treatment,the study group had higher ADL score of(76.39±15.25)points than(63.67±12.31)points in the control group(P<0.05).Compared with before treatment,SDS and SAS scores of both groups decreased after treatment(P<0.05).SDS and SAS scores of the study group were(20.35±2.18)and(19.58±2.06)points,which were significantly lower than(26.52±2.75)and(25.25±2.61)points of the control group(P<0.05).Conclusion Neurorehabilitation therapy has significant clinical efficacy in patients with post-stroke hemiplegia,which is obviously superior to conventional rehabilitation therapy,and can effectively improve patients'neurological function and upper limb motor function,improve patients'activities of daily living,reduce patients'anxiety,depression and other adverse emotions,and shorten patients'rehabilitation cycle,which is worthy of clinical promotion and use.

Post-stroke hemiplegiaNeurorehabilitation therapyNeurological functionClinical research

黄宇

展开 >

110000 辽宁电力中心医院康复医学中心

脑卒中偏瘫 神经康复治疗 神经功能 临床研究

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(9)